Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
01:13:42 EST Sun 08 Feb 2026
Enter Symbol
or Name
USA
CA



Q:UTHR - UNITED THERAPEUTICS CORP - https://www.unither.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
UTHR - Q6.0485.78·490.000.2485.36+6.431.3297.2143,6949,804483.81  489.50  481.95519.99  266.9817:36:24Jan 2615 min RT 2¢

Recent Trades - Last 10 of 9804
Time ETExPriceChangeVolume
17:36:24Q485.806.8724
17:15:04Q485.786.851
16:39:07Q489.9911.061
16:38:42Q489.9911.061
16:26:31Q485.78016.85011
16:26:30Q485.88556.95551
16:20:00Q485.366.4362
16:10:05Q485.366.431
16:10:05Q485.366.431
16:10:04Q485.366.431

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-01-26 07:00U:UTHRNews ReleaseUnited Therapeutics Announces Positive Results from Phase 1 Study of miroliverELAP(TM) in Patients with Acute Liver Failure
2026-01-22 07:00U:UTHRNews ReleaseUnited Therapeutics Corporation Announces Appointment of Kevin J. Tracey to its Board of Directors
2026-01-05 07:00U:UTHRNews ReleaseUnited Therapeutics Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference
2025-11-04 07:00U:UTHRNews ReleaseUnited Therapeutics Corporation to Present at Upcoming Investor Conferences
2025-11-03 07:00U:UTHRNews ReleaseUnited Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease
2025-10-29 06:30U:UTHRNews ReleaseUnited Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results
2025-10-15 07:00U:UTHRNews ReleaseUnited Therapeutics Corporation to Report Third Quarter 2025 Financial Results Before Market Open on Wednesday, October 29, 2025
2025-10-13 07:00U:UTHRNews ReleaseUnited Therapeutics to Feature Clinical Data at the CHEST 2025 Annual Meeting
2025-09-19 07:00U:UTHRNews ReleaseUnited Therapeutics Corporation to Review Data from the Successful TETON-2 Pivotal Study of Nebulized Tyvaso(TM) in Idiopathic Pulmonary Fibrosis
2025-09-16 07:00U:UTHRNews ReleaseUnited Therapeutics Corporation to Present at the Bernstein 2nd Annual Healthcare Forum
2025-09-12 07:00U:UTHRNews ReleaseUnited Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the European Respiratory Society Congress
2025-09-02 07:00U:UTHRNews ReleaseUnited Therapeutics Corporation Announces TETON-2 Pivotal Study of Tyvaso(TM) Meets Primary Endpoint for the Treatment of Idiopathic Pulmonary Fibrosis
2025-08-29 07:00U:UTHRNews ReleaseUnited Therapeutics Corporation to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
2025-08-01 07:00U:UTHRNews ReleaseUnited Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program
2025-07-30 06:30U:UTHRNews ReleaseUnited Therapeutics Corporation Reports Record Second Quarter 2025 Financial Results
2025-07-16 07:00U:UTHRNews ReleaseUnited Therapeutics Corporation to Report Second Quarter 2025 Financial Results Before Market Open on Wednesday, July 30, 2025
2025-06-24 07:00U:UTHRNews ReleaseUnited Therapeutics and Intermountain Health Announce the First Patient Treated With External Liver Support Using a Bioengineered Liver
2025-06-23 07:00U:UTHRNews ReleaseUnited Therapeutics Corporation Concludes Enrollment of the ADVANCE OUTCOMES Study of Ralinepag for the Treatment of Pulmonary Arterial Hypertension
2025-04-30 06:30U:UTHRNews ReleaseUnited Therapeutics Corporation Reports First Quarter 2025 Financial Results
2025-04-21 07:00U:UTHRNews ReleaseUnited Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2025 International Conference